35 | venetoclaxIBA
04/2024
-
01/2017 |
19 | tagraxofuspIBA
04/2024
-
07/2014 |
17 | Cytarabine (Cytosar-U)FDA LinkGeneric
11/2023
-
11/2013 |
17 | ruxolitinibIBA
01/2023
-
03/2015 |
14 | Azacitidine (5 Azacytidine)FDA Link
12/2023
-
01/2015 |
13 | DecitabineFDA Link
01/2022
-
09/2015 |
12 | Tyrosine Kinase InhibitorsIBA
01/2023
-
07/2012 |
9 | Dasatinib (BMS 354825)FDA Link
04/2024
-
07/2012 |
7 | Janus Kinase InhibitorsIBA
11/2023
-
01/2015 |
7 | Idarubicin (4 Demethoxydaunorubicin)FDA LinkGeneric
11/2023
-
11/2013 |
7 | Core Binding Factors (Core-Binding Factor)IBA
01/2023
-
04/2016 |
7 | Hemoglobins (Hemoglobin)IBA
01/2023
-
09/2014 |
6 | Interleukin-3 Receptors (Interleukin 3 Receptor)IBA
12/2023
-
07/2014 |
6 | CladribineFDA LinkGeneric
11/2023
-
01/2014 |
6 | ponatinibIBA
10/2023
-
09/2015 |
6 | Transaminases (Aminotransferases)IBA
01/2023
-
02/2015 |
5 | Proteins (Proteins, Gene)FDA Link
11/2023
-
01/2017 |
5 | BilirubinIBA
11/2023
-
02/2015 |
5 | Inotuzumab OzogamicinIBA
06/2023
-
01/2018 |
5 | fludarabineIBA
01/2023
-
11/2017 |
5 | Clofarabine (Clolar)FDA Link
01/2021
-
11/2013 |
4 | navitoclaxIBA
11/2023
-
01/2022 |
4 | Sorafenib (BAY 43-9006)FDA Link
11/2023
-
01/2019 |
4 | ibrutinibIBA
01/2023
-
01/2019 |
4 | CytokinesIBA
01/2023
-
10/2019 |
4 | NivolumabIBA
01/2023
-
01/2019 |
4 | Rituximab (Mabthera)FDA Link
12/2021
-
02/2015 |
4 | Vincristine (Oncovin)FDA LinkGeneric
12/2018
-
02/2015 |
3 | Chimeric Antigen ReceptorsIBA
01/2023
-
05/2022 |
3 | Phosphotransferases (Kinase)IBA
01/2023
-
01/2017 |
3 | Gemtuzumab (Mylotarg)FDA Link
11/2022
-
01/2020 |
3 | Biomarkers (Surrogate Marker)IBA
06/2022
-
01/2017 |
3 | InterferonsIBA
01/2022
-
12/2020 |
3 | fms-Like Tyrosine Kinase 3IBA
01/2022
-
07/2014 |
3 | Telomerase (Telomerase Reverse Transcriptase)IBA
01/2022
-
10/2019 |
3 | Alanine Transaminase (SGPT)IBA
08/2021
-
11/2015 |
3 | Lenalidomide (CC 5013)FDA Link
01/2021
-
01/2015 |
3 | Aspartate Aminotransferases (Aspartate Transaminase)IBA
10/2019
-
11/2015 |
3 | Prednisone (Sone)FDA LinkGeneric
12/2018
-
09/2014 |
3 | Janus KinasesIBA
01/2017
-
01/2015 |
3 | Imatinib Mesylate (Gleevec)FDA Link
11/2016
-
07/2012 |
3 | nilotinibFDA Link
11/2016
-
07/2012 |
2 | Protein-Tyrosine Kinases (Tyrosine Kinase)IBA
04/2024
-
08/2013 |
2 | Interleukin-3 (Interleukin 3)IBA
12/2023
-
10/2019 |
2 | Diphtheria ToxinIBA
12/2023
-
10/2019 |
2 | Hydroxyurea (Hydrea)FDA LinkGeneric
11/2023
-
01/2023 |
2 | CPX-351IBA
11/2023
-
11/2020 |
2 | PLX51107IBA
11/2023
-
01/2022 |
2 | Apoptosis Regulatory ProteinsIBA
10/2023
-
01/2019 |
2 | blinatumomabIBA
06/2023
-
01/2019 |
2 | NucleophosminIBA
01/2023
-
08/2013 |
2 | Isocitrate Dehydrogenase (Isocitrate Dehydrogenase (NAD+))IBA
11/2022
-
01/2021 |
2 | 11- (2- pyrrolidin- 1- ylethoxy)- 14,19- dioxa- 5,7,26- triazatetracyclo(19.3.1.1(2,6).1(8,12))heptacosa- 1(25),2(26),3,5,8,10,12(27),16,21,23- decaeneIBA
11/2022
-
01/2022 |